[Methotrexate use in patients with systemic lupus erythematosus].
Sánchez
Yunchoy
Y
Departamento de Reumatología, Hospital San Juan de Dios, Santiago de Chile.
Carvallo
Aurelio
A
D000328:Adult; D015415:Biomarkers; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000097:blood / Q000188:drug therapy*; D008727:Methotrexate / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D012189:Retrospective Studies; D013997:Time Factors; D016896:Treatment Outcome
D015415:Biomarkers; D007166:Immunosuppressive Agents; D008727:Methotrexate
Uso de metotrexato en pacientes con lupus eritematoso sistémico.